Arizona State Retirement System Esperion Therapeutics, Inc. Transaction History

Arizona State Retirement System

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$1.46 - $7.3 $3,190 - $15,950	2,185 Added 13.69%	18,147 $28,000
Q4 2022 Feb 07, 2023	BUY	$5.09 - $8.5 $81,246 - $135,677	15,962 New	15,962 $99,000
Q2 2021 Aug 02, 2021	SELL	$19.4 - $28.71 $149,554 - $221,325	-7,709 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$25.12 - $36.89 $193,650 - $284,385	7,709 New	7,709 $216,000
Q4 2020 Jan 28, 2021	SELL	$24.2 - $35.76 $191,567 - $283,076	-7,916 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$31.18 - $52.71 $64,106 - $108,371	2,056 Added 35.09%	7,916 $294,000
Q2 2020 Aug 04, 2020	BUY	$30.04 - $51.31 $176,034 - $300,676	5,860 New	5,860 $301,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.